Easton Pharmaceuticals (Easton Pharmaceuticals) EBITDA Margin % : 0.00% (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Easton Pharmaceuticals's EBITDA for the three months ended in Sep. 2021 was $-0.08 Mil. Easton Pharmaceuticals's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Easton Pharmaceuticals's EBITDA margin for the quarter that ended in Sep. 2021 was 0.00%.

Easton Pharmaceuticals EBITDA Margin % Historical Data

The historical data trend for Easton Pharmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals EBITDA Margin % Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

EBITDA Margin %

Get a 7-Day Free Trial

-1,675.47

-1,931.21

-32.72

-20.76

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Easton Pharmaceuticals's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Easton Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Easton Pharmaceuticals's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easton Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Easton Pharmaceuticals's EBITDA Margin % falls into.

Easton Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Easton Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2020 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2020 )	/	Revenue (A: Dec. 2020 )
	=	-0.189	/	0
	=	%

Easton Pharmaceuticals's EBITDA Margin % for the quarter that ended in Sep. 2021 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2021 )	/	Revenue (Q: Sep. 2021 )
	=	-0.084	/	0
	=	%

Easton Pharmaceuticals (OTCPK:EAPH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Easton Pharmaceuticals EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.